SCHEMBL27365987

SCHEMBL27365987

CC(O)C(C)N1CCN(C(=O)OC(C)(C)C)CC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
HTT P42858 2/20 0.45
ATM Q13315 1/20 0.45
ALDH1A1 P00352 3/20 0.44
MAPT P10636 2/20 0.44
NPC1 O15118 1/20 0.44
MAPK1 P28482 1/20 0.44
RAB9A P51151 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
HRH3 Q9Y5N1 1/20 0.43
HPGD P15428 1/20 0.43
EPHX2 P34913 1/20 0.42
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
RECQL P46063 1/20 0.41
EPHX1 P07099 1/20 0.41
TSHR P16473 1/20 0.41
LMNA P02545 1/20 0.40
POLB P06746 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5599546 0.86 USP2 (0.53) USP2SMN1; SMN2HTTATMALDH1A1
SCHEMBL24670979 0.85 USP2 (0.49) USP2SMN1; SMN2HTTATMALDH1A1
SCHEMBL2737190 0.84 HRH3 (0.58) USP2SMN1; SMN2HTTATMALDH1A1
SCHEMBL25524991 0.82 USP2 (0.46) USP2SMN1; SMN2HTTATMALDH1A1
SCHEMBL19297036 0.82 USP2 (0.46) USP2SMN1; SMN2HTTATMALDH1A1
SCHEMBL22994977 0.82 USP2 (0.46) USP2SMN1; SMN2HTTATMALDH1A1
SCHEMBL18294 0.81 USP2 (0.69) USP2SMN1; SMN2HTTATMALDH1A1
SCHEMBL698803 0.81 USP2 (0.69) USP2SMN1; SMN2HTTATMALDH1A1
SCHEMBL3565907 0.81 USP2 (0.51) USP2SMN1; SMN2HTTATMALDH1A1
SCHEMBL8510395 0.81 USP2 (0.51) USP2SMN1; SMN2HTTATMALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024049929-A2 PANNEXIN-1 MODULATORS AND METHODS OF TREATING DISORDERS IN WHICH PANNEXIN-1 IS IMPLICATED PANNEX THERAPEUTICS INC. (US) 2024-03-07 WO disclosed